The global subcutaneous drug delivery devices market size is expected to reach USD 51.8 billion by 2030, registering to grow at a CAGR of 7.5% from 2024 to 2030 according to a new report by Grand View Research, Inc. The increasing prevalence of chronic conditions combined with regular medicine administration to relive disease symptoms has enhanced the demand for in-home drug administration devices. As per the Centers for Disease Control and Prevention (CDC), in 2018, about 54.4 million adults, amounting to 22.7% suffered from arthritis, fibromyalgia, gout, or lupus in the U.S. The CDC further stated that by 2040, an estimated 78.0 million adults accounting for 26.0% will be diagnosed with arthritis.
In addition, a rising number of biologic medicine approvals for the treatment of life-threatening conditions in patients requiring large dose volumes or extended delivery periods accelerate the demand for subcutaneous drug delivery devices. According to the study published by Informa U.K., in February 2019, the total number of medicines in the clinical trial pipeline increased from 53.0% in 2018 to 55.0% in 2019 for parenteral administrations, with an overall decrease in oral medicine formulations from 33.0% in 2018 to 31.0% in 2019.
Request a free sample copy or view report summary: Subcutaneous Drug Delivery Devices Market Report
North America accounted for the largest revenue share in 2023 owing to the rising prevalence of chronic diseases in the geriatric population and high disposable income
By product, injection pen is expected to register the highest CAGR during the forecast period owing to ease in providing multi-dose medicine and affordability
By distribution channel, the retail pharmacies segment accounted for the largest market share as they include large pharmacy chains and attractive schemes and discounts for the novel medicine delivery devices
Market players are adopting several strategies such as strategic collaborations and product innovations to cater to the increasing patient demand in the global market.
Grand View Research has segmented the global subcutaneous drug delivery device market based on product, distribution channel, and region:
Subcutaneous Drug Delivery Device Product Outlook (Revenue, USD Million, 2018 - 2030)
Prefilled Syringes
Pen Injectors
Auto Injectors
Wearable Injectors
Needle-free Injectors
Subcutaneous Drug Delivery Device Distribution Channel Outlook (Revenue, USD Million, 2018 - 2030)
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Subcutaneous Drug Delivery Device Region Outlook (Revenue, USD Million, 2018 - 2030)
North America
U.S.
Canada
Mexico
Europe
UK
Germany
France
Italy
Spain
Denmark
Sweden
Norway
Asia Pacific
Japan
China
India
Australia
South Korea
Thailand
Latin America
Brazil
Argentina
Middle East & Africa
South Africa
Saudi Arabia
UAE
Kuwait
List of Key Players in Subcutaneous Drug Delivery Device Market
Gerresheimer AG
Medtronic Plc
Ypsomed AG
Elcam Medical Group
Novo Nordisk
Insulet Corporation
Becton, Dickinson and Company
West Pharmaceutical Services, Inc.
PharmaJet
Unilife Corporation
Inolife Sciences
"The quality of research they have done for us has been excellent..."